← Leaderboards
Alexander A. Vinks
Children'S Hospital Med Ctr (Cincinnati)
$6,037,579
Attributed
$7,084,172
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,084,172 · 11
By mechanism
T32$2,243,462 · 1
U10$1,816,195 · 1
R01$1,255,070 · 1
K24$701,199 · 1
R21$639,870 · 2
R34$419,760 · 1
Top collaborators
- Hermine I Brunner3 shared
- Prasad Devarajan1 shared
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Hermine I Brunner$8,150,642
- Susan D Thompson$11,267,165
- Susmita Kashikar-Zuck$15,689,768
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodTraining ProgramsDosePharmaceutical PreparationsChildClinical PharmacologyClinical TrialsDesignDrug KineticsResponseBasePharmacodynamicsSitePharmacodynamic ModelToxic EffectRisperidoneFundingMycophenolate MofetilProgramsBiological MarkersLearningAttentionMentorsPharmacology
Grant awards (37)
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study$1,255,070
R01 · FY2022 · AR
T32 Cincinnati Pediatric Clinical Pharmacology Training Program$86,846
T32 · FY2022 · HD · contact PI
T32 Cincinnati Pediatric Clinical Pharmacology Training Program$169,997
T32 · FY2021 · HD · contact PI
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$203,508
T32 · FY2020 · HD · contact PI
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$214,407
T32 · FY2019 · HD · contact PI
Neonatal PBPK-PD Modeling of Morphine Incorporated with OCT1 Genotype-dependent Developmental Expression$198,750
R21 · FY2019 · HD · contact PI
Improving Pediatric Lupus Nephritis Through Personalized Mycophenolate Mofetil Therapy$174,900
R34 · FY2019 · AR
Improving Pediatric Lupus Nephritis Through Personalized Mycophenolate Mofetil Therapy$244,860
R34 · FY2018 · AR
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$226,081
T32 · FY2018 · HD · contact PI
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$103,214
T32 · FY2017 · HD · contact PI
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$71,010
T32 · FY2017 · HD · contact PI
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$63,612
T32 · FY2017 · HD · contact PI
Cincinnati Pediatric Clinical Pharmacology Postdoctoral Training Program$162,248
T32 · FY2016 · HD · contact PI
Cincinnati Training Program in Pediatric Clinical and Developmental Pharmacology$209,008
T32 · FY2015 · HD · contact PI
Cincinnati Training Program in Pediatric Clinical and Developmental Pharmacology$207,780
T32 · FY2014 · HD · contact PI
Cincinnati Training Program in Pediatric Clinical and Developmental Pharmacology$193,485
T32 · FY2013 · HD · contact PI
Cincinnati Training Program in Pediatric Clinical and Developmental Pharmacology$201,783
T32 · FY2012 · HD · contact PI
Cincinnati Training Program in Pediatric Clinical and Developmental Pharmacology$130,483
T32 · FY2011 · HD · contact PI
Optimizing MMF therapy in pediatric transplant patients$145,476
K24 · FY2010 · HD · contact PI
CHMCC Pediatric Pharmacology Research Unit$151,476
U10 · FY2009 · HD · contact PI
Optimizing MMF therapy in pediatric transplant patients$142,487
K24 · FY2009 · HD · contact PI
CHMCC Pediatric Pharmacology Research Unit$303,233
U10 · FY2008 · HD · contact PI
Optimizing MMF therapy in pediatric transplant patients$141,220
K24 · FY2008 · HD · contact PI
CLINICAL TRIAL: PK-PD MODELS OF MYCOPHENOLIC ACID$520
M01 · FY2008 · RR · contact PI
CHMCC Pediatric Pharmacology Research Unit$315,459
U10 · FY2007 · HD · contact PI
Optimizing MMF therapy in pediatric transplant patients$136,273
K24 · FY2007 · HD · contact PI
PK-PD MODELS OF MYCOPHENOLIC ACID$1,115
M01 · FY2007 · RR · contact PI
CHMCC Pediatric Pharmacology Research Unit$331,522
U10 · FY2006 · HD · contact PI
Optimizing MMF therapy in pediatric transplant patients$135,743
K24 · FY2006 · HD · contact PI
CHMCC Pediatric Pharmacology Research Unit$351,233
U10 · FY2005 · HD
RISPERIDONE PHARMACOKINETICS IN CHILDREN WITH PDD$3,227
M01 · FY2005 · RR
PHARMACOGENETICS OF RISPERIDONE$3,227
M01 · FY2005 · RR
CHMCC Pediatric Pharmacology Research Unit$363,272
U10 · FY2004 · HD
Risperidone Pharmacokinetics in Children with PDD$527
M01 · FY2004 · RR
Risperidone Pharmacokinetics in Children with Pervasive*$145,120
R21 · FY2003 · HD
Risperidone Pharmacokinetics in Children with Pervasive*$148,000
R21 · FY2002 · HD
RISPERIDONE PHARMACOKINETICS IN CHILDREN WITH PDD$148,000
R21 · FY2001 · HD